Betacoronavirus 1
Betacoronavirus 1 is a species of coronavirus which is part of the Betacoronavirus genus. It is known to cause a range of diseases in mammals, including humans. The most well-known member of this species is the Human coronavirus OC43 (HCoV-OC43), a common cause of mild to moderate colds in humans.
Taxonomy[edit]
Betacoronavirus 1 is a member of the genus Betacoronavirus, and the family Coronaviridae. The family Coronaviridae is divided into two subfamilies, Coronavirinae and Torovirinae, and Betacoronavirus 1 belongs to the former. Within the subfamily Coronavirinae, Betacoronavirus 1 is part of the lineage A betacoronaviruses.
Structure and Genome[edit]
Like all coronaviruses, Betacoronavirus 1 is enveloped and has a positive-sense single-stranded RNA genome. The virus particles are spherical, with club-shaped spike projections. The genome is approximately 30,000 to 32,000 bases in length, and encodes for several structural and non-structural proteins.
Pathogenesis and Clinical Features[edit]
In humans, Betacoronavirus 1 primarily causes respiratory infections. The most common clinical manifestation is the common cold, but it can also cause more severe diseases, particularly in individuals with underlying health conditions. Symptoms can include fever, cough, sore throat, and runny nose. In rare cases, it can lead to severe lower respiratory tract infections like pneumonia and bronchitis.
Prevention and Treatment[edit]
There is currently no specific treatment for infections caused by Betacoronavirus 1. Management is primarily supportive, and can include rest, hydration, and over-the-counter medications to relieve symptoms. Prevention strategies include regular hand hygiene, avoiding close contact with infected individuals, and covering the mouth and nose when coughing or sneezing.
See Also[edit]
| Coronaviruses and related topics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Coronaviruses related article is a stub.
|
| Infectious diseases – viral systemic diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
-
Betacoronavirus 1
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
